Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)
OTCMKTS
· Delayed Price · Currency is USD
1.120
0.00 (0.00%)
At close: Jul 1, 2025
Genomma Lab Internacional Revenue
Genomma Lab Internacional had revenue of 4.41B MXN in the quarter ending March 31, 2025, with 4.98% growth. This brings the company's revenue in the last twelve months to 18.82B, up 14.13% year-over-year. In the year 2024, Genomma Lab Internacional had annual revenue of 18.61B with 12.99% growth.
Revenue (ttm)
18.82B MXN
Revenue Growth
+14.13%
P/S Ratio
1.16
Revenue / Employee
11.30M MXN
Employees
1,665
Market Cap
1.07B USD
Revenue Chart
* This company reports financials in MXN.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18.61B | 2.14B | 12.99% |
| Dec 31, 2023 | 16.47B | -352.79M | -2.10% |
| Dec 31, 2022 | 16.82B | 1.33B | 8.61% |
| Dec 31, 2021 | 15.49B | 1.62B | 11.66% |
| Dec 31, 2020 | 13.87B | 1.16B | 9.10% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 84.04M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
Genomma Lab Internacional News
- 15 days ago - GENOMMA LAB INTERNACIONAL ANNOUNCES TWELFTH DIVIDEND PAYMENT - PRNewsWire
- 26 days ago - GENOMMA LAB INTERNATIONAL INFORMS TOTAL PREPAYMENT OF "LAB 23" UNSECURED LOCAL BOND (CEBUR) - PRNewsWire
- 4 weeks ago - Genomma Lab successfully issued the LAB 25 and LAB 25-2 unsecured bonds (Cebures) for a total amount of $1.2 billion pesos, which will be used to prepay liabilities, including the full early amortization of the LAB 23 bond - PRNewsWire
- 2 months ago - Q1 2025 Genomma Lab Internacional SAB de CV Earnings Call Transcript - GuruFocus
- 2 months ago - Genomma Lab Internacional Announces Results for the First Quarter 2025 - PRNewsWire
- 3 months ago - Genomma Lab Internacional S.A.B. de C.V. First Quarter 2025 Earnings Results Conference Call - PRNewsWire
- 4 months ago - GENOMMA LAB INTERNACIONAL ANNOUNCES ELEVENTH DIVIDEND PAYMENT - PRNewsWire
- 4 months ago - Genomma Lab Internacional Announces Results for the Fourth Quarter and Full Year 2024 - PRNewsWire